Fibrinogen Deficiency Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results | Biotest AG, GC Pharma (GC녹십자), LFB

Fibrinogen deficiency, also known as factor I deficiency, is an inherited bleeding disorder which prevent blood clot formation in the human body. Hypofibrinogenemia, afibrinogenemia, dysfibrinogenemia and hypodysfibrinogenemia are most commonly occurring fibrinogen deficiency disorders.

Download the sample report at: https://www.pharmaproff.com/request-sample/1037

The symptoms of this deficiency vary based on the type of disorder. However, some most common symptoms reported among various types of fibrinogen deficiency disorders are nose bleeding, bruising, heavy menstrual bleeding, muscle bleeding, abnormal bleeding after circumcision, pregnancy complications; abnormal bleeding during or after injury, surgery, and childbirth; and mouth bleeding.

Get the detailed analysis at: https://www.pharmaproff.com/report/fibrinogen-deficiency-therapeutics-pipeline-analysis

The standard treatments available for these disorders are fibrinogen concentrates, cryoprecipitate and fresh frozen plasma (FFP) prepared from human plasma. Some of the major companies involved in development of therapeutic agents for the management of fibrinogen deficiency include Biotest AG, Green Cross Corporation, LFB SA and others. For instance, Biotest AG is in the process of developing BT-524, a human fibrinogen concentrate purified from human plasma, for the treatment of fibrinogen deficiency disorders.

Make enquiry before purchase at: https://www.pharmaproff.com/enquiry/1037

• The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials.
• Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.

About Us:
Pharma Proff, is a frontline market intelligence and consulting solutions provider catering to the information and data needs of burgeoning sectors across the world, including pharmaceutical and healthcare. With meticulously curated research reports on the industry landscape, we empower companies in the healthcare and pharmaceutical sectors to make informed business decisions and base their marketing strategies with astuteness.

Contact:
Pharma Proff
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@pharmaproff.com
Web: https://www.pharmaproff.com

This release was published on openPR.